tm logo
PONSTEVIA
ABANDONED SECTION 36

on 21 Sep 2020

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1909217 filed on 12th Jul 2018

PONSTEVIA

Trademark usage description

pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alzheimer's disease, anxiety disorders, atopic dermatitis, autoim Read More

Classification Information


Class [005]
Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases. central nervous system diseases and disorders namely, anxiety disorders, depression. bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type I Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel disease, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.


Classification kind code

11

Mark Details


Serial Number

1909217

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 14
on 08th Jan 2020
Default Notice Sent
Submitted for opposition 190
on 20th Jun 2019
Registration Pending
Submitted for opposition 191
on 20th Jun 2019
Registration Fee Notice Sent
Submitted for opposition 42
on 06th Mar 2019
Advertised
Submitted for opposition 26
on 28th Feb 2019
Approved
Submitted for opposition 22
on 09th Jan 2019
Search Recorded
Submitted for opposition 27
on 09th Jan 2019
Approval Notice Sent
Submitted for opposition 31
on 16th Jul 2018
Formalized
Submitted for opposition 1
on 13th Jul 2018
Created
Submitted for opposition 30
on 12th Jul 2018
Filed